Concepedia

William Duggan

WD

Statistics

Publications

20

Citations

3.1K

H-Index

16

Active since

1999

Affiliations

Pfizer (United States)(Current)

Amsterdam UMC Location University of Amsterdam

Baylor University Medical Center

University of Amsterdam

Cleveland Clinic

William Duggan is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

1999–2021

20

Publications

20

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

Steven E. Nissen, Jean‐Claude Tardif, Stephen J. Nicholls et al. · New England Journal of Medicine · 2007 · 965 citations · Full text

, , +12

Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia

John J.P. Kastelein, Sander I. van Leuven, Leslie Burgess et al. · New England Journal of Medicine · 2007 · 665 citations

, , +17

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

Michiel L. Bots, Frank L.J. Visseren, Gregory W. Evans et al. · The Lancet · 2007 · 458 citations

, , +8

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

Paul M. Ridker, Jean‐Claude Tardif, Pierre Amarenco et al. · New England Journal of Medicine · 2017 · 364 citations · Full text

, , +17

Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia

Christie M. Ballantyne, Joel Neutel, Anne Cropp et al. · The American Journal of Cardiology · 2015 · 168 citations · Full text

, , +16

1–5 of 20